Education
About Us
Working with TipRanks
Follow Us
Daniel Lynch Insider Profile
4 Followers
Daniel Lynch, Director at Carisma Therapeutics, holds 161.43K shares in Carisma Therapeutics (Ticker: CARM), holds ― shares in Surface Oncology (Ticker: SURF), holds ― shares in Translate Bio (Ticker: ~TBIO).
Daniel Lynch has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Daniel Lynch holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Daniel Lynch
Daniel Lynch's Trading History
Carisma Therapeutics
Feb 13, 2014
Director
Uninformative Buy
―
$63.28K
Surface Oncology
―
―
―
―
Translate Bio
―
―
―
―
Springworks Therapeutics
Jul 02, 2025
―
Uninformative Sell
―
$0.00
2seventy bio
Jun 15, 2023
―
Uninformative Buy
―
$105.27K
Bluebird Bio
Jun 17, 2021
―
Uninformative Buy
―
$39.56K
DNIB Unwind, Inc.
―
―
―
$0.00
Blueprint Medicines
Jun 26, 2020
Director
Uninformative Buy
―
$16.56M
List of latest transactions for each holding click on a transaction to see Daniel Lynch's performance on stock
You May Also Like
Daniel Lynch insider profile FAQ
What is the percentage of profitable transactions made by Daniel Lynch?
The percentage of profitable transactions made by Daniel Lynch is ―.
What is the average return per transaction made by Daniel Lynch?
The average return per transaction made by Daniel Lynch is ―.
What stocks does Daniel Lynch hold?
Daniel Lynch holds: CARM, SURF, ~TBIO, SWTX, TSVT, BLUE, BINDQ, BPMC stocks.
What was Daniel Lynch’s latest transaction?
Daniel Lynch latest transaction was an Uninformative Buy of ―.
What was Daniel Lynch's most profitable transaction?
Daniel Lynch’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Daniel Lynch's role in Carisma Therapeutics?
Daniel Lynch's role in Carisma Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.